Security
HISTOGEN INC Common Stock · HSTOQ
HSTOQOTCCommon stockHistorical · closed Jan 5, 2026CIK 1383701Updated Nov 16, 2026
Name history
Conatus Pharmaceuticals Inc. · through May 21, 2020Conatus Pharmaceuticals Inc · through Jun 23, 2014
HSTOQ price & chart
Historical security
This listing closed Jan 5, 2026. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2022 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 19,073,000Source | 27,245,000Source | 15,013,000Source | 21,827,000Source |
| Property, Plant and Equipment, NetUSD | 436,000Source | 399,000Source | 271,000Source | 0Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 12,109,000Source | 18,685,000Source | 6,763,000Source | 20,703,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 99,000Source | 165,000Source | 144,000Source | — |
| Inventory, NetUSD | — | — | 300,000Source | — |
| Assets, CurrentUSD | 13,456,000Source | 21,609,000Source | 8,400,000Source | 21,606,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 848,000Source | 2,359,000Source | 1,183,000Source | 781,000Source |
| Operating Lease, Right-of-Use AssetUSD | 4,658,000Source | 4,432,000Source | 4,411,000Source | 221,000Source |
| Other Assets, NoncurrentUSD | 523,000Source | 805,000Source | 1,931,000Source | 221,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 5,697,000Source | 7,059,000Source | 8,100,000Source | — |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | — | — | — | 0Source |
| Common Stock, Value, IssuedUSD | 5,000Source | 5,000Source | 1,000Source | 3,000Source |
| Retained Earnings (Accumulated Deficit)USD | -88,273,000Source | -77,652,000Source | -62,702,000Source | -198,014,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | — | — | — | 0Source |
| Stockholders' Equity Attributable to ParentUSD | 14,405,000Source | 21,192,000Source | 7,860,000Source | 20,187,000Source |
| Additional Paid in Capital, Common StockUSD | 102,673,000Source | 98,839,000Source | 70,561,000Source | 218,198,000Source |
| Liabilities and EquityUSD | 19,073,000Source | 27,245,000Source | 15,013,000Source | 21,827,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 1,234,000Source | 2,330,000Source | 2,785,000Source | 1,640,000Source |
| Operating Lease, Liability, CurrentUSD | 238,000Source | 127,000Source | 28,000Source | 338,000Source |
| Accounts Payable, CurrentUSD | 382,000Source | 1,393,000Source | 539,000Source | — |
| Operating Lease, Liability, NoncurrentUSD | 4,379,000Source | 4,617,000Source | 4,806,000Source | — |
| Other Liabilities, NoncurrentUSD | — | — | 22,000Source | — |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | -1,029,000Source | -1,006,000Source | -947,000Source | — |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 595,000Source | 791,000Source | 1,880,000Source | — |
| Deferred Revenue, CurrentUSD | 19,000Source | 19,000Source | 48,000Source | — |
| Deferred Revenue, NoncurrentUSD | 79,000Source | 98,000Source | 118,000Source | — |
| Long-term DebtUSD | — | — | 369,000Source | — |
cash flow · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -10,644,000Source | -15,009,000Source | -18,817,000Source | -11,385,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation and amortization | — | — | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 502,000Source | 704,000Source | 618,000Source | 4,153,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -66,000Source | 21,000Source | 34,000Source | — |
| Increase (Decrease) in InventoriesUSD | — | -239,000Source | 396,000Source | — |
| Increase (Decrease) in Accounts PayableUSD | -1,011,000Source | 854,000Source | -881,000Source | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -9,683,000Source | -14,532,000Source | -12,054,000Source | -20,202,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -216,000Source | -241,000Source | 10,969,000Source | 29,337,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 216,000Source | 241,000Source | 49,000Source | 11,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | — | — | — | 0Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 3,323,000Source | 27,085,000Source | 5,783,000Source | 3,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -6,576,000Source | 12,312,000Source | 4,698,000Source | 9,138,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 12,509,000Source | 19,085,000Source | 6,773,000Source | — |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 1,000Source | 6,000Source | 63,000Source | 0Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 502,000Source | 704,000Source | 618,000Source | 4,200,000Source |
| Debt Securities, Available-for-sale, Realized Gain (Loss)USD | — | — | — | 0Source |
| DepreciationUSD | — | — | — | 73,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | -17,000Source | — | — |
| General and Administrative ExpenseUSD | 9,391,000Source | 7,796,000Source | 6,586,000Source | 10,196,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | — |
| Inventory Write-downUSD | 61,000Source | — | 202,000Source | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | — | -11,385,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -23,000Source | -59,000Source | -48,000Source | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -11,109,000Source | -14,950,000Source | -18,769,000Source | — |
| Nonoperating Income (Expense)USD | — | — | — | 621,000Source |
| Operating ExpensesUSD | 14,412,000Source | 16,489,000Source | 20,917,000Source | 33,723,000Source |
| Operating Lease, Impairment LossUSD | — | — | — | 50,000Source |
| Other Nonoperating Income (Expense)USD | — | 458,000Source | 105,000Source | 53,000Source |
| Proceeds from Issuance of Common StockUSD | 4,405,000Source | 20,738,000Source | 5,098,000Source | 0Source |
| Proceeds from Stock Options ExercisedUSD | — | — | 40,000Source | — |
income statement · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Total RevenueUSD | 3,769,000Source | 1,032,000Source | 2,059,000Source | 21,717,000Source |
| Operating Income (Loss)USD | -10,643,000Source | -15,457,000Source | -18,858,000Source | -12,006,000Source |
| Other Nonoperating Income (Expense)USD | — | 458,000Source | 105,000Source | 53,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | — |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -23,000Source | -59,000Source | -48,000Source | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | — | -11,385,000Source |
| Earnings Per Share, BasicUSD per share | -3.46Source | — | — | — |
| Earnings Per Share, DilutedUSD per share | -3.46Source | — | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 3,211,139Source | — | — | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 3,211,139Source | — | — | — |
| Additional Financial Items | ||||
| Depreciation, Depletion and Amortization, NonproductionUSD | 140,000Source | 97,000Source | 98,000Source | — |
| General and Administrative ExpenseUSD | 9,391,000Source | 7,796,000Source | 6,586,000Source | 10,196,000Source |
| Interest ExpenseUSD | — | — | — | 0Source |
| Investment Income, NetUSD | -1,000Source | -10,000Source | -64,000Source | 568,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -11,109,000Source | -14,950,000Source | -18,769,000Source | — |
| Nonoperating Income (Expense)USD | — | — | — | 621,000Source |
| Operating ExpensesUSD | 14,412,000Source | 16,489,000Source | 20,917,000Source | 33,723,000Source |
| Preferred Stock Dividends, Income Statement ImpactUSD | 488,000Source | — | — | — |
| Research and Development ExpenseUSD | 5,021,000Source | 8,473,000Source | 6,219,000Source | 23,527,000Source |